Skip to main content

Test announcement

Announcement here about some event or update. Or maybe link to promoted article. 

Main navigation

  • Home
  • Culture
    • Humor
    • Mathematics
    • Random Thoughts
    • Science & Society
    • Sports Science
    • Technology
  • Earth Sciences
    • Atmospheric
    • Energy
    • Environment
    • Geology
    • Oceanography
    • Paleontology
  • Life Sciences
    • Ecology & Zoology
    • Evolution
    • Immunology
    • Microbiology
    • Neuroscience
  • Medicine
    • Aging
    • Cancer Research
    • Clinical Research
    • Pharmacology
    • Public Health
    • Vision
  • Physical Sciences
    • Aerospace
    • Applied Physics
    • Chemistry
    • Optics
    • Physics
    • Space
  • Social Sciences
    • Anthropology
    • Archaeology
    • Philosophy & Ethics
    • Psychology
    • Science History
  • Contributors
X XD

User menu

  • Log in
ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody

ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody

LEUVEN, Belgium, LUND, Sweden and BASEL, Switzerland, June 18 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR) and BioInvent International AB (Nordic Exchange: BINV) announce that they have…
Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research

Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research

SAN DIEGO, June 17 /PRNewswire/ -- - Strong Government Support Continues to Draw Top Research Institutes, Talent, and Corporate Labs That Are Looking to Place Strategic Bets for the Future Singapore…
Axelar Initiates Phase I/II Clinical Trial on Cancer Patients With the New Anti-Cancer Drug AXl1717

Axelar Initiates Phase I/II Clinical Trial on Cancer Patients With the New Anti-Cancer Drug AXl1717

STOCKHOLM, June 17 /PRNewswire/ -- Axelar AB today announced that the company recently has initiated a phase I/II clinical trial on cancer patients with its new anti-cancer drug AXL1717, an insulin-…
Coffee Drinkers Have Slightly Lower Death Rate From Heart Disease

Coffee Drinkers Have Slightly Lower Death Rate From Heart Disease

A new study published today in Annals of Internal Medicine has good news for coffee drinkers: Regular coffee drinking (up to 6 cups per day) is not associated with increased deaths in either men or…
Children From Three Primary Schools Meet Prince William at Charity Polo Match for WellChild

Children From Three Primary Schools Meet Prince William at Charity Polo Match for WellChild

CHELTENHAM, England, June 14 /PRNewswire/ -- - With Photo Children from Bishop Stortfor College, Hornsby House School in South London and The Catholic School of St Gregory The Great in Cheltenham…
VELCADE(R) (bortezomib) Data Highlights Superior Quantity and Quality Responses

VELCADE(R) (bortezomib) Data Highlights Superior Quantity and Quality Responses

BEERSE, Belgium, June 14 /PRNewswire/ -- - 30 Percent Complete Response Rate Compared to 4 Percent With Current Drug Treatment Standard of Care - Abstract Number: 0473 Janssen-Cilag / Ortho Biotech…
New Roche Chlamydia Test Approved for Use in European Union

New Roche Chlamydia Test Approved for Use in European Union

PLEASANTON, California, June 13 /PRNewswire/ -- - Test offers more reliable detection of Chlamydia trachomatis, the most commonly reported sexually transmitted disease in Europe. Roche announced…
Treating Pain Effectively - New Study Results Confirm Improved Gastrointestinal Tolerability of Tapentadol

Treating Pain Effectively - New Study Results Confirm Improved Gastrointestinal Tolerability of Tapentadol

PARIS and AACHEN, Germany, June 13 /PRNewswire/ -- Results from two phase III clinical studies of tapentadol immediate release tablets (IR) suggest a significantly improved gastrointestinal…
HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings Fr

HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings Fr

PARIS, June 13 /PRNewswire/ -- - Rheumatoid Arthritis is the Leading Cause of Work Disability in Europe New data announced today showed that treating patients with early, active rheumatoid arthritis…
New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis

New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis

PARIS, June 13 /PRNewswire/ -- Seven-year rheumatoid arthritis (RA) data from open-label extension studies show that treatment with Abbott's HUMIRA(R) (adalimumab) resulted in clinical remission…

Pagination

  • Previous page ← Prev
  • Page 81
  • Page 82
  • Page 83
  • Page 84
  • Current page 85
  • Page 86
  • Page 87
  • Page 88
  • Page 89
  • Next page Next →
Subscribe to Cancer Research

Donate

Please donate so science experts can write for the public.

At Science 2.0, scientists are the journalists, with no political bias or editorial control. We can't do it alone so please make a difference.

Donate with PayPal button 
We are a nonprofit science journalism group operating under Section 501(c)(3) of the Internal Revenue Code that's educated over 300 million people.

You can help with a tax-deductible donation today and 100 percent of your gift will go toward our programs, no salaries or offices.

More reads

Featured Image

If Your Doctor Talks About Homeopathy, You Have A Terrible Doctor

Homeopathy, a belief from 200 years ago that if you took something that mimicked the symptoms of a disease you could prevent a disease, or that extremely diluted water with a molecule of something…
Featured Image

Even Thinking About Marriage Gets Young People To Straighten Up

COLUMBUS, Ohio - You don't have to get married to settle down and leave behind your wild ways - you just have to expect to get married soon. Researchers found that teenagers and young adults who…
Featured Image

Defining Microbiome Deviancy Down: Now Even Nanoparticles Impact Your Gut?

Though our guts contain a trillion bacteria in various compositions, it's become popular to claim any detectable change is a bad thing. Unless it is to sell yogurt, where no detectable change is…
Featured Image

Buprenorphine Is A Schedule III Drug For Opioid Addiction - Taking It Off Prescription Will Save Lives

There is no question the government and its hand-picked advisors have hyped claims of opioid addiction beyond all sense. Doctors, pharmaceutical companies, and legitimate pain patients have all been…

Footer

  • About Us
  • Copyright and Removal
  • Privacy Policy
  • Terms